CSFBACE1 activity is increased in CJD and Alzheimer disease other dementias

被引：63
作者：
Holsinger, R. M. D.
Lee, J. S.
Boyd, A.
Masters, C. L.
Collins, S. J.
机构：
[1] Univ Melbourne, Parkville, Vic 3052, Australia
[2] Mental Hlth Res Inst, Parkville, Vic, Australia
[3] Australian Natl Creutzfeldt Jakob Dis Registry, Melbourne, Vic, Australia
来源：
NEUROLOGY | 2006年 / 67卷 / 04期
基金：
英国医学研究理事会;
关键词：
D O I：
10.1212/01.wnl.0000229925.52203.4c
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
To assess the diagnostic utility of CSF BACE1 activity for discriminating Alzheimer disease ( AD) from other dementias, particularly Creutzfeldt-Jakob disease (CJD), the authors studied 26 patients with sporadic CJD, 21 patients with AD, and 21 patients with various non-AD, non-CJD dementias (DCs). CSF BACE1 activity was elevated in AD in comparison with DC (p = 0.01). Unexpectedly, CSF BACE1 activity was also increased in sporadic CJD (p = 0.02).
引用
收藏
页码：710 / 712
页数：3
相关论文
共 10 条
  • [1] Cerebrospinal fluid tau levels in neurodegenerative diseases with distinct tau-related pathology
    Arai, H
    Morikawa, Y
    Higuchi, M
    Matsui, T
    Clark, CM
    Miura, M
    Machida, N
    Lee, VMY
    Trojanowski, JQ
    Sasaki, H
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 236 (02) : 262 - 264
  • [2] tau protein in cerebrospinal fluid - A biochemical marker for axonal degeneration in Alzheimer disease?
    Blennow, K
    Wallin, A
    Agren, H
    Spenger, C
    Siegfried, J
    Vanmechelen, E
    [J]. MOLECULAR AND CHEMICAL NEUROPATHOLOGY, 1995, 26 (03) : 231 - 245
  • [3] Novel prion protein gene mutation in an octogenarian with Creutzfeldt-Jakob disease
    Collins, S
    Boyd, A
    Fletcher, A
    Byron, K
    Harper, C
    McLean, CA
    Masters, CL
    [J]. ARCHIVES OF NEUROLOGY, 2000, 57 (07) : 1058 - 1063
  • [4] Assessment of CSF levels of tan protein in mildly demented patients with Alzheimer's disease
    Galasko, D
    Clark, C
    Chang, L
    Miller, B
    Green, RC
    Motter, R
    Seubert, P
    [J]. NEUROLOGY, 1997, 48 (03) : 632 - 635
  • [5] Cerebrospinal fluid brain-derived proteins in the diagnosis of Alzheimer's disease and Creutzfeldt-Jakob disease
    Green, AJE
    [J]. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2002, 28 (06) : 427 - 440
  • [6] Increased expression of the amyloid precursor β-secretase in Alzheimer's disease
    Holsinger, RMD
    McLean, CA
    Beyreuther, K
    Masters, CL
    Evin, G
    [J]. ANNALS OF NEUROLOGY, 2002, 51 (06) : 783 - 786
  • [7] Increased β-secretase activity in cerebrospinal fluid of Alzheimer's disease subjects
    Holsinger, RMD
    McLean, CA
    Collins, SJ
    Masters, CL
    Evin, GV
    [J]. ANNALS OF NEUROLOGY, 2004, 55 (06) : 898 - 899
  • [8] Highly increased CSF tau protein and decreased β-amyloid (1-42) in sporadic CJD:: a discrimination from Alzheimer's disease?
    Kapaki, E
    Kilidireas, K
    Paraskevas, GP
    Michalopoulou, M
    Patsouris, E
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2001, 71 (03) : 401 - 403
  • [9] Decreased β-amyloid1-42 in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease
    Otto, M
    Esselmann, H
    Schulz-Schaeffer, W
    Neumann, M
    Schröter, A
    Ratzka, P
    Cepek, L
    Zerr, I
    Steinacker, P
    Windl, O
    Kornhuber, J
    Kretzschmar, HA
    Poser, S
    Wiltfang, J
    [J]. NEUROLOGY, 2000, 54 (05) : 1099 - 1102
  • [10] Cell biology of protein misfolding: The examples of Alzheimer's and Parkinson's diseases
    Selkoe, DJ
    [J]. NATURE CELL BIOLOGY, 2004, 6 (11) : 1054 - 1061
1